The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

Genesis Energy (NYSE:GEL) is expected to report earnings for its fourth quarter. • Gogoro (NASDAQ:GGR) is likely to report earnings for its fourth quarter. • LXP Industria ...

March S&P 500 E-Mini futures (ESH26) are up +0.33%, andMarch Nasdaq 100 E-Mini futures (NQH26) are up +0.23% this morning, ...

Finance Minister Nirmala Sitharaman proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics, positioning India as a global bio-pharma hub to combat non-communicable diseases like ...

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

Bio-Rad Laboratories (NYSE:BIO) executives said the company finished 2025 within revised guidance for revenue and operating ...

Bio-Rad Laboratories, Inc. ( BIO) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST Good day, everyone, and welcome to the ...

Bio-Rad Laboratories shares fell as the company faces margin pressure related to declining academic research funding. The stock slipped 10.6% to $261.43 Friday. Shares are down 14% over the past 12 ...

Radiology has come up multiple times as an example of a field that’s been impacted by AI without replacing the need for human workers.

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of ...